Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer.
Masuda T, Ueo H, Okumura Y, Kai Y, Ando Y, Masuguchi K, Kitagawa M, Kitagawa A, Hayashi N, Tsuruda Y, Hisamatsu Y, Suehiro S, Ohmura H, Fujiyoshi K, Tanaka F, Mimori K. Masuda T, et al. Among authors: hisamatsu y. Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):182-194. doi: 10.21873/cgp.20373. Cancer Genomics Proteomics. 2023. PMID: 36870689 Free PMC article.
Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
Mochizuki K, Kudo SE, Kato K, Kudo K, Ogawa Y, Kouyama Y, Takashina Y, Ichimasa K, Tobo T, Toshima T, Hisamatsu Y, Yonemura Y, Masuda T, Miyachi H, Ishida F, Nemoto T, Mimori K. Mochizuki K, et al. Among authors: hisamatsu y. PLoS One. 2022 Oct 20;17(10):e0273566. doi: 10.1371/journal.pone.0273566. eCollection 2022. PLoS One. 2022. PMID: 36264865 Free PMC article.
Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence.
Hosoda K, Toshima T, Takahashi J, Yonemura Y, Hisamatsu Y, Hirose K, Masuda T, Motomura Y, Abe T, Ando Y, Dairaku K, Nakano Y, Hashimoto M, Hiraki Y, Soejima Y, Yoshizumi T, Mimori K. Hosoda K, et al. Among authors: hisamatsu y. Int Cancer Conf J. 2023 Jun 23;12(4):274-278. doi: 10.1007/s13691-023-00618-6. eCollection 2023 Oct. Int Cancer Conf J. 2023. PMID: 37577350
Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers.
Kobayashi Y, Niida A, Nagayama S, Saeki K, Haeno H, Takahashi KK, Hayashi S, Ozato Y, Saito H, Hasegawa T, Nakamura H, Tobo T, Kitagawa A, Sato K, Shimizu D, Hirata H, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Mizuno S, Kawazu M, Kohsaka S, Ueno T, Mano H, Ishihara S, Uemura M, Mori M, Doki Y, Eguchi H, Oshima M, Suzuki Y, Shibata T, Mimori K. Kobayashi Y, et al. Among authors: hisamatsu y. Br J Cancer. 2023 Oct;129(7):1105-1118. doi: 10.1038/s41416-023-02395-8. Epub 2023 Aug 18. Br J Cancer. 2023. PMID: 37596408
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer.
Hashimoto M, Masuda T, Nakano Y, Tobo T, Saito H, Koike K, Takahashi J, Abe T, Ando Y, Ozato Y, Hosoda K, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Hata T, Uemura M, Eguchi H, Doki Y, Mori M, Mimori K. Hashimoto M, et al. Among authors: hisamatsu y. Cancer Sci. 2024 Mar 17. doi: 10.1111/cas.16129. Online ahead of print. Cancer Sci. 2024. PMID: 38494600 Free article.
182 results